- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Nexium, Nexium 24HR, Esomeprazole DR, Esomeprazole
Synonyms :
esomeprazole
Class :
Drugs for peptic ulcer & Proton pump inhibitors
when both drugs are combined, there may be a decrease in levels of serum concentration and absorption of erlotinib
it may decrease the serum concentration of bosutinib
may decrease the serum concentration
belumosudil: they may diminish the serum concentration of Inhibitors of the Proton Pump
may decrease the diagnostic effect of each other when combined
it may decrease the absorption of Levoketoconazole
may decrease the serum concentration
they decrease the concentration of active metabolites of infigratinib in the serum
it may diminish the therapeutic effect of Immune Checkpoint Inhibitors
it may diminish the therapeutic effect of Immune Checkpoint Inhibitors
it may diminish the therapeutic effect of Immune Checkpoint Inhibitors
may diminish the therapeutic effect of bisphosphonate derivative
may diminish the therapeutic effect of bisphosphonate derivative
may diminish the therapeutic effect of bisphosphonate derivative
may diminish the therapeutic effect of bisphosphonate derivative
may diminish the therapeutic effect of bisphosphonate derivatives
may diminish the therapeutic effect of bisphosphonate derivatives
may diminish the therapeutic effect of bisphosphonate derivatives
may diminish the therapeutic effect of bisphosphonate derivatives
may diminish the therapeutic effect of immune checkpoint inhibitors
may diminish the therapeutic effect of immune checkpoint inhibitors
may diminish the therapeutic effect of immune checkpoint inhibitors
Inhibitors of the Proton Pump: they may decrease the therapeutic effect of oral bisphosphonate derivatives
Inhibitors of the Proton Pump: they may decrease the therapeutic effect of oral bisphosphonate derivatives
Inhibitors of the Proton Pump: they may decrease the therapeutic effect of oral bisphosphonate derivatives
Inhibitors of the Proton Pump: they may decrease the therapeutic effect of oral bisphosphonate derivatives
Inhibitors of the Proton Pump: they may decrease the therapeutic effect of oral bisphosphonate derivatives
When bacampicillin is combined with esomeprazole, bacampicillin absorption and blood levels decrease by stomach acid reduction.
when both drugs are combined, there may be an increased risk of hypomagnesemia
Proton Pump inhibitors may increase the absorption of amphetamine
it may decrease the serum concentration of Atazanavir
l-methylfolate-pyridoxal 5′-phosphate-methylcobalamine
it may decrease the serum concentration of Multivitamins
it may decrease the serum concentration of Minerals
it may decrease the serum concentration of Minerals
it may decrease the serum concentration of Minerals
it may decrease the serum concentration of Minerals
it may decrease the serum concentration of Minerals
may increase the serum concentration of itraconazole
they decrease the efficacy of cysteamine
This could lead to a reduction in concentration serum of mycophenolate
it enhances the level of bismuth subsalicylate by increasing the gastrointestinal absorption
it enhances the effect of alprazolam by diminishing the metabolism
Frequency defined:
1%-10%
Abdominal pain
Constipation
Diarrhea
Nausea
Dizziness
Headache
Pregnancy consideration: No adverse effects have been reported in animal reproduction studies. It can be recommended for the treatment of GERD in pregnant women. (maternal dose 10 mg/day)
Lactation: Esomeprazole can be excreted in breast milk, use with caution.
Pregnancy category:
<1%:
Bradycardia
Chest pain
Pruritis
Decreased libido
Diabetes mellitus
Goiter
Abdominal distension
Pregnancy consideration: No adverse effects have been reported in animal reproduction studies. It can be recommended for the treatment of GERD in pregnant women. (maternal dose 10 mg/day)
Lactation: Esomeprazole can be excreted in breast milk, use with caution.
Pregnancy category:
Patient information leaflet
Generic Name: Esomeprazole
Pronounced: es-me-pra-zole
Why do we use esomeprazole?
Esomeprazole is a proton pump inhibitor. It is used to decrease acid secretion in gastric parietal cells and treat esophagitis, acid reflux (GERD), peptic ulcers, and H.pylori infection.